Lexagene Holdings Inc (fka LXXGQ)

[imjake]

If I am not mistaken, they don't own the original 2 patents. They have exclusive license to develop the tech from the gov't agency the CEO previously worked for. As to the buyout talk, I hope they don't jump the gun. A typical premium for biotech buyout offers is 80%, or so one of your links in a previous post stated. Well our stock price is ridiculously low so that just wouldn't do IMO. This seems to be a simple machine to manufacture and I hope they can ramp up with similar ease, as I could see them flying out the door to the thousands of testing labs and agencies that need this technology badly. It's amazing what this LX2 has been proven it can do! And the LX2 sales are (the 'razor') just the beginning. The real money is in the 'blades' so to speak. 90% margin on the one-time use, disposable test cartridges!! And the test sites go through them like water.